Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-label, Multicenter, Effectiveness and Safety Study of Once Daily AZILECT® as Mono- or Adjunct Therapy in Patients With Idiopathic Parkinson's Disease (PD)

NCT00399477 is registered in ClinicalTrials.gov with Teva Neuroscience, Inc. as lead sponsor.

NCT NCT00399477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-label, Multicenter, Effectiveness and Safety Study of Once Daily AZILECT® as Mono- or Adjunct Therapy in Patients With Idiopathic Parkinson's Disease (PD)
Lead sponsor
Teva Neuroscience, Inc.
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2006
Completion date
July 31, 2007
Enrollment
200 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease